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A major challenge facing the genetics of autism spectrum disorders
(ASDs) is the large and growing number of candidate risk genes and
gene variants of unknown functional significance. Here, we used
Caenorhabditis elegans to systematically functionally characterize
ASD-associated genes in vivo. Using our custom machine vision sys-
tem, we quantified 26 phenotypes spanning morphology, locomo-
tion, tactile sensitivity, and habituation learning in 135 strains each
carrying a mutation in an ortholog of an ASD-associated gene. We
identified hundreds of genotype–phenotype relationships ranging
from severe developmental delays and uncoordinated movement
to subtle deficits in sensory and learning behaviors. We clustered
genes by similarity in phenomic profiles and used epistasis analysis
to discover parallel networks centered on CHD8•chd-7 and NLGN3•nlg-1
that underlie mechanosensory hyperresponsivity and impaired ha-
bituation learning. We then leveraged our data for in vivo func-
tional assays to gauge missense variant effect. Expression of wild-
type NLG-1 in nlg-1 mutant C. elegans rescued their sensory and
learning impairments. Testing the rescuing ability of conserved
ASD-associated neuroligin variants revealed varied partial loss of
function despite proper subcellular localization. Finally, we used
CRISPR-Cas9 auxin-inducible degradation to determine that phe-
notypic abnormalities caused by developmental loss of NLG-1 can
be reversed by adult expression. This work charts the phenotypic
landscape of ASD-associated genes, offers in vivo variant func-
tional assays, and potential therapeutic targets for ASD.
autism spectrum disorder | neurodevelopmental disorders | Caenorhabditis
elegans | habituation learning | variants of uncertain significance
Autism spectrum disorders (ASDs) encompass a clinically andgenetically heterogeneous group of neurodevelopmental
disorders characterized by deficits in social communication and
interaction, restrictive repetitive behaviors, and profound sensory
processing abnormalities (1–4). The fifth edition of the Diagnostic
and Statistical Manual of Mental disorders combines autistic dis-
order, Asperger disorder, childhood disintegrative disorder, and
pervasive developmental disorder not otherwise specified into the
single grouping of autism spectrum disorder (1). Despite extensive
study, there is currently no unanimously agreed upon structural or
functional neuropathology common to all individuals with ASD,
and there is little understanding of the biological mechanisms that
cause ASD (3). The most promising avenue for research into ASDs
has stemmed from the observation that they have a strong genetic
component, with monozygotic concordance estimates of ∼70 to
90% and several distinct highly penetrant genetic syndromes (3, 4).
Rapid advances in copy number variation association, whole-
exome, and more recently, whole-genome sequencing tech-
nology and the establishment of large sequencing consortia,
have dramatically increased the pace of gene discovery in ASD
(5–9). There are now >100 diverse genes with established ties
to ASD, many of which are being used in diagnosis. Impor-
tantly, each gene accounts for <1% of cases and none have
shown complete specificity for ASD, with many implicated in
multiple neurodevelopmental disorders (3, 4, 8). Some of these
genes have fallen into an encouragingly small set of broadly
defined biological processes such as gene expression regulation
(e.g., chromatin modification) and synaptic neuronal commu-
nication (3, 6–8, 10). Seminal studies using mouse models,
genetically stratified populations of individuals with ASD, human
induced pluripotent stem cells (iPSCs), and, more recently, high-
throughput genetic model organisms such as Drosophila and
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zebrafish have investigated the molecular, circuit, and behavioral
phenotypic disruptions that result from mutations in diverse ASD-
associated genes. These systems have offered valuable insights into
the biological mechanisms underlying this heterogeneous group of
disorders (11–24). However, thousands of additional mutations in
these and many other genes have been identified in individuals
with ASD, and their roles as causative agents, or their pathoge-
nicity, remain ambiguous. Thus, there are 2 major challenges
facing ASD genetics: (1) the large, growing number of candidate
risk genes with poorly characterized biological functions and (2)
the inability to predict the functional consequences of the large
number of rare missense variants. Difficulties in rare missense
variant interpretation stem in part from constraints on computa-
tional variant effect prediction and a paucity of in vivo experi-
mental variant functional assays (25, 26). This lag between gene
discovery and functional characterization is even more pro-
nounced when assessing the role of putative ASD risk genes and
variants in complex sensory and learning behaviors. As such, there
is a great need to rapidly determine the functions of ASD-
associated genes and the functional consequences of variants of
uncertain significance and to delineate complex functional genetic
networks among ASD-associated genes in vivo.
The genetic model organism Caenorhabditis elegans is a powerful
system for the functional analysis of disease-associated genetic
variation, particularly for high-throughput in vivo characterization
of risk genes identified through genomics (27). C. elegans’s fully
sequenced and thoroughly annotated genome and complete con-
nectome have fueled numerous disease discoveries, including the
identification of presenilins as part of the gamma secretase com-
plex and the role of the insulin signaling pathway in normal and
pathological aging (27–30). There are clear C. elegans orthologs
for >50% of human genes, and human genes have repeatedly been
shown to be so structurally and functionally conserved that they
can directly replace their C. elegans ortholog (27, 31–33). There
are well-annotated libraries of C. elegans strains with deletion al-
leles available for >16,000 of the ∼20,000 protein coding genes
(34). C. elegans’s small size and rapid hermaphroditic mode of
reproduction (3 d from egg to egg-laying adult) allows for the
routine cultivation of large numbers of isogenic animals. Further,
CRISPR-Cas9 genome engineering is reliable and efficient in C.
elegans, and, unlike most organisms analyzed to date, rigorous
whole-genome sequencing studies have revealed no significant off-
target effects due to CRISPR-Cas9 genome editing in this or-
ganism (34, 35). Finally, we developed the Multi-Worm Tracker
(MWT), a machine vision system that allows for comprehensive
phenotypic analysis of large populations of freely behaving animals
while they perform complex sensory and learning behaviors (36,
37). Multiplexing by running several trackers in parallel allows
for analysis of multiple measures of morphology, locomotion,
mechanosensory sensitivity, and several forms of learning in hun-
dreds of animals simultaneously.
Here, we developed a scalable phenomic characterization
pipeline to discover functions of ASD-associated genes by system-
atically inactivating each gene in a model organism and observing
the phenotypic consequences using machine vision (SI Appendix,
Fig. S1A). We present data summarizing scores on 26 quantitative
phenotypes spanning morphology, baseline locomotion, tactile sen-
sitivity, and habituation learning in 135 strains of C. elegans each
carrying a mutation in an ortholog of an ASD-associated gene, re-
vealing hundreds of shared and unique genotype–phenotype rela-
tionships. We clustered strains based on phenotypic similarity to
discover functional interactions among ASD-associated genes, which
we validate with epistasis analysis. Further, we use the phenotypic
profiles for in vivo functional assays to assess missense variant effect,
and to determine whether phenotypic alterations are reversible us-
ing targeted protein degradation methods based on degrons.
Results
ASD-Associated Genes Are Highly Conserved to C. elegans. We
identified C. elegans orthologs of the 102 genes associated with
increased risk for ASD (FDR ≤ 0.1) according to Satterstrom
et al. (8), the largest exome sequencing study of ASD to date
(35,584 individuals, 11,986 ASD cases). We also identified
numerous orthologs from SFARI Gene (https://gene.sfari.org/)
“syndromic” and “high confidence” categories and the top 50 ASD-
associated genes by variant count from our ongoing meta-analysis
of rare variants, VariCarta (https://varicarta.msl.ubc.ca/index) (38).
Of note, 72% (18/25) of genes in the SFARI high confidence
category and 78% (80/102) of genes associated with ASD by
Satterstrom et al. (8) have a clear C. elegans ortholog according to
OrthoList2 and the Alliance of Genome Resources, compendiums
of human–C. elegans orthology prediction algorithm results. This is
substantially higher than the 53% estimated genome-wide orthol-
ogy between humans and C. elegans (10,678/23,010) (32), sug-
gesting an exceptionally high conservation of biological processes
core to ASD pathology (SI Appendix, Fig. S1 B and C).
Rapid advances in gene discovery and orthology prediction
have altered the gene lists used during the course of this project.
Despite this challenge, our list covers 92% (58/63) of the most
strongly associated genes from Satterstrom et al. (8) and 100%
(15/15) of the SFARI Gene high confidence category genes
(Datasets S1 and S2) that had an assay-suitable ortholog deletion
or severe missense allele available. This mix of currently defined
high- and mid-confidence ASD-associated genes offered a unique
opportunity to study putative ASD-associated genes of unknown
function alongside genes with known roles in neurodevelopment
and sensory processing (Datasets S1 and S2 provide a complete
listing of characterized strains, orthology relationships, and ASD-
association confidence).
We then used our MWT (SI Appendix, Fig. S1D) to systemati-
cally characterize the 135 C. elegans strains with a mutation in an
ortholog of an ASD-associated gene (98 strains with mutations in
different genes and 37 strains with additional alleles of a subset of
these genes; Dataset S1 and SI Appendix). We developed software
to measure a comprehensive range of parameters while animals were
subjected to an automated short-term habituation learning behav-
ioral paradigm (SI Appendix, Fig. S1 E–I; further details provided in
Materials and Methods and SI Appendix). We measured habituation
because it is a sensitive in vivo assay of synaptic function and be-
havioral plasticity. Habituation is also impaired in individuals with
ASD, and abnormalities in tactile sensitivity are present in >95% of
cases (2, 39, 40). The degree of habituation impairment in ASD
correlates with the severity of social impairment, and recent studies
in monogenic mouse models of ASD suggest peripheral tactile hy-
persensitivity and impaired habituation precede, and may even lead
to, more complex cognitive and social impairments (2, 39, 40).
We wrote custom scripts to extract 26 quantitative phenotypic
features that fall into 5 categories: morphology, baseline loco-
motion, initial sensitivity, habituation learning, and spontaneous
recovery/short-term memory retention (SI Appendix, Fig. S2A and
Table S1 provide complete feature descriptions). Features were
designed to minimize redundancy while maintaining interpret-
ability. For example, we quantified multiple features of habitua-
tion because we have previously shown these response components
habituate to different extents and with different time courses (SI
Appendix, Fig. S1 F–I) and because growing evidence indicates
different components of a single habituating response are mediated
by different molecular mechanisms (37, 41–43). Quantification of
correlations between all possible phenotypic feature pairs revealed
expected moderate correlations (e.g., between length and width)
and clustering that reflected the feature categories we predefined
(SI Appendix, Fig. S2B). Digital representations of all strains
are freely available in their raw and processed forms (https://
dataverse.scholarsportal.info/dataset.xhtml?persistentId=doi:10.5683/
SP2/FJWIL8) (44), allowing the code to be modified to extract any
simple or compound phenotypic feature of choice.
Quantitative Phenotypic Profiles Identify Shared Functions Among
ASD-Associated Genes. One way to visualize these data is as a se-
ries of 26 quantitative reverse genetic screens, where each strain is
compared to wild-type on each phenotypic feature to determine if
and how that gene plays a role in the biological process of interest
2 of 12 | www.pnas.org/cgi/doi/10.1073/pnas.1912049116 McDiarmid et al.
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(Fig. 1 and Dataset S3). Phenotypes shared by a large number of
ASD risk genes were of particular interest, as they would suggest
common biological functions among these seemingly diverse genes.
We found that mutations in the vast majority of ASD-associated
gene orthologs decrease multiple measures of size, most notably
length (77/135, 57%), in age-synchronized populations (Fig. 1A).
Thus, the majority of genes putatively associated with ASD/neuro-
developmental disorders delay development or impede growth
when inactivated.
Analysis of baseline locomotion revealed that mutations in a
large proportion of ASD-associated gene orthologs increase
forward movement bias and path length (distance traveled; SI
Appendix, Fig. S3A). This means many strains with mutations in
ASD-associated gene orthologs spent more time moving forward
before reversing. The frequency and duration of spontaneous
reversals is modulated by the integration of multiple cross-modal
sensory inputs (45), suggesting a widespread imbalance in the
neural circuits that control spontaneous forward movement
behavior toward increased activity in strains harboring mutations
in orthologs of ASD-associated genes.
Assessing the duration, distance, and speed of reversal responses
to the first mechanosensory stimulus indicated that mutations in
orthologs of ASD-associated genes are approximately equally
likely to result in initial hyper- or hyporesponsivity to tactile stimuli
(SI Appendix, Fig. S3B; bidirectional analysis of initial sensi-
tivity was precluded only for response probability due to a
ceiling effect with >90% of animals responding to the initial
stimulus). These results identify positive and negative roles for
multiple ASD-associated genes in modulating mechanosensory
processing.
Analysis of habituation learning across 135 strains revealed
that mutations in many ASD-associated gene orthologs specifically
impair habituation of response probability (Fig. 1C). Even after
filtering out strains with abnormal initial response probability,
ASD-associated gene orthologs were ∼3-fold more likely to impair
habituation than enhance it (Fig. 1D and Dataset S3). This is a
remarkably specific phenotype that causes the neural circuit to
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Fig. 1. Phenotypic profiles enable rapid reverse genetic screens to identify shared functions among ASD-associated genes. Plots illustrate sample mean
distance of each genotype group from wild-type. Strains outside the 95% confidence interval of the wild-type distribution are labeled and colored blue. A
maximum of 5 strains are labeled in each direction to prevent overplotting. (A) Length by genotype. (B) Initial response duration by genotype. (C) Habituation
of response probability by genotype. Error bars represent 95% confidence interval. (D) The number of strains with normal initial responses that either impair
habituation (blue) or enhance habituation (gray) across the 4 response metrics quantified.
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continue responding in an inflexible manner, versus merely
impairing the ability to detect stimuli or respond. Importantly, we
only observed this phenomenon for response probability; there was
no such consistent pattern of habituation impairment for the du-
ration, distance, or speed of the same measured responses (Fig. 1D
and Dataset S3). Together, these results suggest that many ASD-
associated genes normally mediate plasticity of the likelihood, but
not vigor, of responding to mechanosensory stimuli.
Finally, we discovered that distinct sets of genes alter initial
sensitivity, habituation, and retention of the same component of the
same behavioral response (Fig. 1C and SI Appendix, Fig. S3, and
Dataset S3). Adding to the complexity, we also found that different
genes affect different components of the same behavior (e.g., some
genes affect only response duration but not probability and vice
versa). These results support the hypothesis that habituation is
controlled by several dissociable genetic mechanisms (43) and
underscore the need to assess multiple complex phenotypes to
understand the functions of ASD-associated genes.
Phenotypic Profiles of Strains with Mutations in ASD-Associated
Genes Define Shared and Unique Functions. In addition to visualiz-
ing scores of all strains on each phenotype, one can also visualize
the scores of each strain on all phenotypes, or the “phenotypic
profile” for each strain (Fig. 2 and Dataset S4). Classical un-
coordinated “unc” mutants, such as the calcium channel subunit
CACNA1E•unc-2(gk366), displayed the most severe phenotypic
profiles, consistent with their documented roles in neuronal de-
velopment and function (Fig. 2A). Phenotypic profiles also revealed
previously unknown phenotypes even in well-characterized mutants.
For example, β-catenin has well-known roles in development,
so it follows that CTNNB1•bar-1(ga80) mutants are smaller
than wild-type animals. However, here we identify a previously
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Fig. 2. Phenotypic profiles of strains with mutations in ASD-associated genes define shared and unique functions. (A) Phenotypic profile for CACNA1E•unc-2(gk366).
(B) Phenotypic profile for CTNNB1•bar-1(ga80). (C) Phenotypic profile for KAT2B•pcaf-1(tm3318). (D) Phenotypic profile for KCNJ10•irk-3(tm7416).
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unknown role for β-catenin in habituation learning, evidenced
by a profound deficit in habituation of response probability in
CTNNB1•bar-1(ga80) mutants (Fig. 2B). Animals carrying muta-
tions in KAT2B•pcaf-1(tm3318), involved in CREB-related tran-
scription coactivation and acetyltransferase activity, have relatively
normal baseline locomotion but profound alterations in sensory
and learning behaviors that are only revealed through stimulation
(Fig. 2C). Conversely and more surprisingly, animals carrying
mutations in genes such as KCNJ10•irk-3(tm7416), an inward
rectifying potassium channel, have relatively normal sensory and
learning behaviors despite profoundly abnormal morphology and
baseline locomotion (Fig. 2D). Finally, several strains were not
significantly different from wild-type on almost all phenotypic
features, such as the membrane palmitoylated protein encoded by
MPP6•C50F2.8(ok533) (SI Appendix, Fig. S4 and Dataset S4).
Together, these results indicate a remarkable degree of phenotypic
modularity and provide a catalog of the unique phenotypic profiles
of ASD-associated genes.
A Phenomic Database of Strains with Mutations in ASD-Associated
Genes. Fig. 3A summarizes the scores of ∼27,000 animals (∼200
animals per genotype) across 135 genotypes and 26 phenotypes
for a total of 3,510 in vivo genotype-to-phenotype assessments
(Fig. 3A and Datasets S5 and S6). We included several annotations
on this heat map and reverse genetic screen plots to denote current
estimates of ASD-association confidence and specificity (Fig. 3A
and Datasets S7 and S8). For the phenotypes quantified and strains
tested, no single phenotype is affected by all putative ASD-associated
gene orthologs (Fig. 3A). However, all strains were significantly
different from wild-type on at least 1 phenotypic metric (Fig. 3B). A
larger number of strains displayed altered morphological and base-
line locomotion phenotypes compared to sensory or learning phe-
notypes (Fig. 3B). Finally, our results indicate that distinct, partially
overlapping sets of genes influence the different classes of pheno-
types (e.g., naïve sensitivity and habituation learning are influenced
by different sets of ASD-associated genes; Fig. 3 A and B).
While there are many potential downstream uses for this data-
base, we endeavored to illustrate a few of the most promising
applications. First, we clustered the mutant strains based on their
similarity in overall phenotypic profiles with the hypothesis, sup-
ported by recent large-scale model organism phenotyping efforts,
that phenotypic similarity would enrich for functional genetic in-
teractions among ASD-associated genes. However, while it has
been successful for C. elegans morphology and baseline locomo-
tion profiles in the past (46–52), a large-scale phenotypic clustering
approach has not been attempted in combination with complex
sensory and learning phenotypes. Before clustering, we confirmed
the sensitivity and consistency of our phenotypic measures by ex-
amining the correlation of independently generated alleles tar-
geting the same gene within the set of strains we tested. Our
sample contained 33 genes represented by multiple independently
generated alleles (29 genes with secondary alleles and 4 with both
secondary and tertiary alleles targeting the same gene). Analysis of
the distribution of the overall phenomic correlations between the
same gene-independent allele pairs revealed that the average cor-
relation was indeed higher than all other possible gene pairs (n =
9,004) and that the same gene allele pair distribution was skewed
toward highly positive correlations (SI Appendix, Fig. S5A). We also
included heat maps illustrating only genotype–phenotype relation-
ships seen in all independent alleles of a given gene (Dataset S6).
We then used several clustering methods to group genes based
on phenotypic similarity to predict genetic interactions. Hierar-
chical clustering accurately identified several well-known in-
teractions, such as those between voltage-gated calcium channels
CACNA1E•unc-2, Syntaxin binding proteins STXBP1•unc-18, and
Rab3 binding proteins RIMS1•unc-10 (Fig. 3A and Datasets S5
and S9) (53, 54). Our analysis also confirmed recently discovered
interactions, such as those between the dual specificity kinase
DYRK1A•mbk-1 and the histone acetyltransferase CREBBP•cbp-1,
and predicted several new interactions (Fig. 3A and Datasets S5
and S9) (55). We then investigated the overall phenotypic
architecture of ASD-associated genes. t-distributed stochastic
neighbor embedding (t-SNE) and multiple other clustering
methods revealed that ASD-associated genes were largely con-
tinuously distributed in phenotypic space (SI Appendix, Fig. S5B).
We found no evidence for a small number of highly discrete
clusters that would suggest distinct “phenotypic classes” of ASD-
associated genes (Fig. 3A and SI Appendix, Fig. S5B).
Next, we used epistasis analysis to test some of our interactions
predicted by phenotypic proximity in vivo. Using sensory and
habituation learning features for hierarchical clustering revealed
2 high-confidence clusters with members that display impaired
habituation of response probability and hyperresponsivity to
mechanosensory stimuli (increased initial reversal response dura-
tion; Fig. 4 A and B and SI Appendix, Fig. S6 A and B and Dataset
S9). Genes within these clusters were selected for epistasis analysis
based on confidence of ASD association and confirmation of
genotype-to-phenotype relationships using analysis of a second
allele or transformation rescue. Crossing strains within the same
cluster revealed a functional interaction between the Chromodo-
main Helicase DNA Binding Protein CHD8•chd-7(gk306) and the
GTPase-activating protein GAPVD1•rme-6(b1014); the impair-
ment in habituation of response probability of double mutants was
not significantly different from single mutants, suggesting that they
function in the same genetic pathway to mediate short-term behav-
ioral plasticity (Fig. 4C). A second allele of GAPVD1•rme-6(tm6649)
and an additional allele of CHD8•chd-7(gk209) tested after the
large-scale characterization also displayed the same phenotypic
profile, confirming genotype-to-phenotype relationships (SI Ap-
pendix, Fig. S7). CHD8 is a high-confidence ASD-associated gene
whereas GAPVD1 is relatively low confidence, yet, when they are
inactivated in a model organism, they cause strikingly similar phe-
notypic profiles and function together to promote normal habituation
learning.
Crossing between clusters revealed that CHD8•chd-7(gk306)
and the sole C. elegans ortholog of vertebrate neuroligins NLGN1/
2/3/4X•nlg-1(ok259) function in parallel genetic pathways, with
double mutants exhibiting additive impairments in habituation
(Fig. 4C). Interestingly, we also discovered a synthetic lethal in-
teraction between CHD8•chd-7(gk306) and CTNNB1•bar-1(ga80),
suggesting CHD8 can function independently of its canonical role
in mediating the Wnt/β-catenin signaling pathway (56). These re-
sults are consistent with the observation that Wnt/β-catenin targets
are neither up-regulated nor the cause of lethality in CHD8 ho-
mozygous knockout mice (57), suggesting that Wnt-independent
functions of CHD8 are present in multiple species (58). We
combined our results with the recent observation that Wnt/
β-catenin signaling increases expression and synaptic clustering
of NLGN3 (59) to draw parallel pathways underlying impaired
habituation (Fig. 4D). Together, these results demonstrate that
systematic phenotypic clustering and epistasis analysis of com-
plex sensory and learning phenotypes present an in vivo ap-
proach to map functional genetic network interactions among
ASD-associated genes and prioritize candidates that would be
missed by focusing on currently high-confidence genes.
Phenomic Profiles Can Be Leveraged for In Vivo Variant Functional
Assays.Another challenge facing ASD is the inability to interpret
the functional consequences of the large number of rare variants
of uncertain significance (25). Many variants found in ASD are
so rare they preclude traditional genetic approaches to infer
pathogenicity (25, 26). Experimental variant functional assays,
where the variant is introduced into a model system, can be
combined with computational approaches to guide clinical assess-
ment, but there is a paucity of such assays for most ASD-associated
genes due to a lack of understanding of their normal biological
functions (25, 60, 61). Here, we show how the phenomic functional
data we generated by studying inactivating mutations in ASD-
associated gene orthologs can be combined with the genetic trac-
tability of C. elegans to develop in vivo variant functional assays
using complex sensory and learning behaviors as a readout.
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In our large-scale characterization, we discovered that muta-
tions in the C. elegans ortholog of vertebrate neuroligins cause
impairments in habituation of response probability. We generated
a wild-type nlg-1::YFP fusion transgene and found that expression
of this construct in nlg-1(ok259) deletion mutants was sufficient to
restore normal habituation learning (Fig. 5 A–C and SI Appendix,
Fig. S8A). We then used this transgenic rescue to assess the
functional consequences of mutations equivalent to 4 conserved
ASD-associated neuroligin missense variants by testing their ability
to rescue, revealing varied partial loss of function (Fig. 5 D–G).
We found similar results for these variants on 3 additional be-
havioral functional assays: octanol avoidance chemotaxis, ther-
motaxis, and sensory integration (SI Appendix, Fig. S9). Each of
these functional assays involve distinct neural circuits, suggesting a
general partial loss-of-function mechanism due to ASD-associated
neuroligin variants in whole organism behavior. All ASD-associated
variants were expressed at similar levels and properly local-
ized to synapses in vivo, likely ruling out a simple pathogenic
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mechanism of improper trafficking or severely reduced cellular
abundance (Fig. 5B). We also characterized 2 additional neu-
roligin variant lines generated with a precise CRISPR-Cas9 ge-
nome engineering method (61) and again observed varied
partial loss of function (Fig. 5H). Finally, we assessed 5 addi-
tional missense variants in chd-7 (orthologous to CHD8 and
CHD7) also generated with CRISPR-Cas9 and observed that
P165L•P253L and R2627Q•R2624Q displayed wild-type func-
tion and habituated normally, while L834P•L1220P, G996S•G1225S,
and L1257R•L1487R displayed impairments in habituation learn-
ing (Fig. 5 I–K). Importantly, all ASD-associated gene orthologs,
including those with no prior functional annotation, were signifi-
cantly different from wild-type animals on at least one phenotypic
metric in our characterization (Fig. 3B), suggesting this will be a
broadly applicable approach to decipher variants of uncertain
significance.
CRISPR-Cas9 Auxin-Inducible Degradation Reveals That nlg-1 Phenotypes
Are Reversible by Adult-Specific Reexpression. Historically, it was
believed that the neurodevelopmental insults caused by monogenic
risk factors for ASD were so severe that they would not be re-
versible in adulthood, and thus any treatment would have to be
administered early to be effective. The seminal discoveries that
phenotypes caused by mutations in MECP2 could be reversed by
transgenic expression of the protein in adulthood, after a presumed
critical developmental period had passed, offered tremendous
hope for families suffering from Rett syndrome (62). Conversely,
the observation that inactivation of MECP2, neuroligins, and sev-
eral other ASD-associated genes in adulthood could cause severe
electrophysiological and behavioral impairments demonstrated
that they were not simply neurodevelopmental genes, and instead
that they function throughout the lifespan to promote normal
sensory and learning behaviors (63–65). Such conditional rescue
and inactivation experiments are valuable to ASD research, but
they are expensive, technically difficult, and time-consuming in
mammalian model systems and are thus not yet practical for many
genes. With C. elegans, however, conditional and reversible
protein depletion is precise, rapid, and straightforward owing
to their genetic tractability and the recent advent of CRISPR-
Cas9 auxin-inducible degradation (AID) (66). AID relies on
transgenic expression of TIR1, an inducible E3 ubiquitin ligase
that targets any protein with an AID degron peptide tag for deg-
radation by the proteasome only when in the presence of its ac-
tivating hormone auxin (Fig. 6). Moreover, upon removal from
auxin, TIR1 is inactivated, allowing rapid reconstitution of protein
expression in large populations of freely behaving and intact ani-
mals without the need for surgery or vector delivery (66).
Despite extensive study, adult transgenic rescue tests of be-
havioral phenotype reversibility have not been completed for any
member of the vertebrate neuroligin family (53, 67). We used the
CRISPR-Cas9 dual marker selection (DMS) cassette genome
editing strategy to insert GFP and a short AID degron peptide tag
into the endogenous C. elegans neuroligin locus 13 residues before
the stop codon (Fig. 6A; further details provided in SI Appendix,
99 
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Fig. 4. Combining phenotypic clustering and epistasis analysis to map parallel genetic networks underlying hyperresponsivity and impaired habituation.
(A and B) Hierarchical clustering based on sensory and learning features identified 2 sets of genes with members that display impairments in habituation of
response probability and hyperresponsivity to mechanosensory stimuli (increased initial reversal response duration). Rectangles outline the largest clusters
with AU P values >95%. (C) Final reversal probability across genotypes (average of the 28th to 30th responses). Dots represent individual plate means, and
horizontal lines represent median of plate replicates. Binomial logistic regression followed by Tukey’s honestly significant difference (HSD) criterion was used
to determine significance of the habituated level (proportion reversing at tap 30) for each pair of strains (***P < 0.001). (D) Parallel genetic pathways of ASD-
associated genes underlie impaired habituation learning.
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SI Materials and Methods). This fusion protein localized properly
to synapses and is fully functional; there were no habituation
impairments or gross neuroanatomical abnormalities in genome-
edited animals (Fig. 6 C and D and SI Appendix, Fig. S8B). We
then crossed this strain into animals expressing TIR1 under a
ubiquitous promoter and observed that treatment with 0.025 mM
auxin for <10.0 h was sufficient for complete degradation of the
functional NLG-1::AID::GFP fusion protein at multiple life stages
(Fig. 6D). Moreover, NLG-1::AID::GFP was partially recovered
48 h after removal from auxin (Fig. 6D). We used this approach to
test several conditional rescue and inactivation groups simulta-
neously (Fig. 6E). Animals reared on auxin for continuous deg-
radation displayed habituation impairments equivalent to those of
nlg-1(ok259) null mutants, confirming effective degradation (Fig.
6F). Importantly, wild-type animals continuously exposed to auxin
displayed no morphological or behavioral abnormalities (Fig. 6G).
Strikingly, we observed that, for animals reared on auxin to
degrade NLG-1 throughout development, adult-specific expres-
sion of neuroligin was sufficient to partially rescue the habitua-
tion impairment phenotype (Fig. 6H). Surprisingly, adult-specific
degradation of neuroligin did not lead to impaired habituation
(Fig. 6I). These results indicate a critical role for neuroligin in
generating a circuit properly tuned for normal mechanosensory
processing and short-term behavioral plasticity. Further, they
suggest behavioral disruptions caused by developmental loss of
neuroligins might be at least partially reversible by adult ex-
pression. Given the speed of machine vision phenotyping and
relative ease of CRISPR-Cas9 genome editing in C. elegans, AID
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Fig. 5. Functional assessment of ASD-associated missense variants. (A) Schematic of the nlg-1(ok259) deletion allele and NLG-1::YFP transgene. Lollipops
indicate the approximate locations of the equivalent ASD-associated variants assessed. Note the R430C variant in C. elegans NLG-1 corresponds to a mutation
in human NLGN3 whereas the R62W, V397M, and R714C NLG-1 variants correspond to mutations in human NLGN4X. (B) All neuroligin variants were
expressed at similar levels and localized properly to synapses in the nerve ring and nerve cords. A, anterior; P, posterior; D, dorsal; V, ventral; NR, nerve ring.
(Scale bar: 0.02 mm.) (C) Expression of wild-type NLG-1::YFP rescued nlg-1(ok259) deletion mutant impaired habituation of response probability. (D–G) Each
neuroligin variant was scored for its ability to rescue impaired habituation of response probability, revealing varied partial loss of function. (H) Missense
variants in nlg-1 generated with CRISPR-Cas9 also displayed varied partial loss of function with corresponding impairments in habituation. Note the G59R and
A268T variants in C. elegans NLG-1 correspond to variants in human NLGN4X. (I–K) P165L•P253L and R2627Q•R2624Q missense variants in C. elegans CHD-7
did not display habituation impairments, while L834P•L1220P, G996S•G1225S, and L1257R•L1487R displayed impairments in habituation. Note that the
G1225S, L1487R, and R2624Q missense variants in C. elegans CHD-7 correspond to variants in human CHD7, while L1220P and P253L correspond to variants in
human CHD8. (C–K) Data shown as mean ± SEM using plates as n. Binomial logistic regression followed by Tukey’s HSD criterion was used to determine
significance of the habituated level (proportion reversing at tap 30) for each pair of strains (***P < 0.001). n.s., not significant.
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Fig. 6. CRISPR-Cas9 auxin-inducible degradation reveals phenotypes caused by developmental loss of neuroligin can be rescued by adult reexpression. (A) The
modified DMS cassette genome editing strategy used to insert GFP and a short degron tag into the endogenous neuroligin locus. The maroon line in the repair
template indicates the location of an engineered silent mutation in the protospacer adjacent motif to prevent cleavage of exogenous DNA. (B) Schematic of the
NLG-1::AID::GFP transgene. In the presence of auxin, TIR1 is activated targeting the fusion protein for degradation. Following auxin treatment, TIR1 is inactivated,
allowing conditional degradation and reexpression of the fusion protein. (C) The fusion protein is fully functional; NLG-1::AID::GFP animals did not display ha-
bituation impairments before (Top) or after (Bottom) DMS cassette excision. (D) The fusion protein localizes properly to synapses in the nerve ring and nerve cords
(Top). Treatment with 0.025 mM auxin is sufficient for complete degradation of the fusion protein (Middle) that is reversible 48 h after removal from auxin
(Bottom). A, anterior; P, posterior; D, dorsal; V, ventral; NR, nerve ring. (Scale bar: 0.02mm.) (E) Period of auxin administration for each group. (F) Continuous auxin
administration recapitulated impairments in habituation of response probability. (G) Wild-type•N2 animals continuously treated with auxin exhibited normal
habituation. (H) Adult-specific reexpression of neuroligin partially rescued impaired habituation. Solid blue circles represent continuous auxin administration group
(as in F). (I) Adult-specific degradation of neuroligin did not induce habituation impairments (solid blue circles as in F). (C, F, and I) Binomial logistic regression
followed by Tukey’s HSD criterion was used to determine significance of the habituated level (proportion reversing at tap 30) for each pair of strains (***P < 0.001).
n.s., not significant. Data shown as mean ± SEM using plates as n.
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represents a scalable approach that can be applied to diverse
ASD-associated genes.
Discussion
We quantified 26 phenotypes for >27,000 animals across 135
genotypes and identified hundreds of genotype–phenotype
relationships. When combined with a recent aggregation of all
other machine vision behavioral datasets collected in this organism
to date, our database more than doubles the number of tracked
animals reported in the literature from ∼15,000 to >30,000 (68).
By making the raw and processed data available online, we have
created open and shareable phenotypic atlas of C. elegans strains
carrying mutations in orthologs of ASD-associated genes. We have
shown how this database can be used to identify shared functions,
map genetic networks, gauge missense variant effect, and deter-
mine reversibility of phenotypic disruptions.
We found that the vast majority of strains with mutations in
ASD-associated genes displayed delayed development or growth
impediments, a finding consistent with a recent large-scale analysis
of inactivating mutations in constrained genes in humans (69). We
also found that a large number of ASD-associated genes impair
habituation, a finding consistent with a recently reported large-
scale analysis of ASD- and intellectual disability/developmental
delay-associated genes in Drosophila and humans (70). Interest-
ingly, our data show that ASD-associated genes specifically im-
pair habituation of response probability. These results provide a
genotype-to-phenotype list (Fig. 1C) that may hint at a common
pathological mechanism that impairs plasticity of a neural circuit’s
decision to respond without altering response vigor. Indeed, these
Drosophila and C. elegans results may reflect a behavioral out-
come of circuit-level hyperexcitability recently discovered in sev-
eral human iPSC-derived neuronal culture models of a number of
monogenic ASD risk factors (71, 72). The results also provide a
potentially plausible explanation for inconsistent reports of im-
paired habituation in humans, which variably employ diverse re-
sponse metrics most often without genetic stratification of patient
populations (15, 39). While these shared phenotypes are exciting,
our results and those of several other model systems (11, 15, 19,
22, 70, 71) reveal a remarkable diversity in phenotypic disruptions,
suggesting that single phenotype functional validation and char-
acterization efforts will be insufficient to capture the complex
multifaceted phenotypic disruptions that stem from mutations in
ASD-associated genes.
Phenomic Clustering and Epistasis to Map Genetic Networks Among
ASD-Associated Genes In Vivo.We combined phenotypic clustering
with epistasis analysis to map functional genetic networks among
ASD-associated genes and identified parallel genetic networks
centered on CHD8•chd-7 and NLGN1/2/3/4X•nlg-1 that underlie
hyperresponsivity and impaired habituation. These results provide
in vivo functional support to the proposed broad categorization of
ASD-associated genes into those involved in synaptic neuronal
communication (neuroligin) and gene expression regulation (CHD8)
(6, 8). An exciting question for future research will be to determine
how well the phenomic functional interactions delineated here
map onto biochemical interactions. Indeed, in vivo genetic net-
works will serve as an important benchmark from which to com-
pare and extend existing networks of ASD-associated genes.
Phenomic clustering will be particularly useful for capturing long-
range functional interactions between proteins expressed in dif-
ferent cells or even different points in development, which cannot
be detected by measures of direct protein–protein interactions or
coexpression.
The strains we characterized were generally continuously
distributed in phenotypic space, and we did not detect highly
separated discrete phenotypic clusters. Even in this carefully
controlled genetic background and environment, we found no
evidence for distinct phenotypic classes of ASD-associated genes.
This is in contrast to the molecular level, where multiple studies
and our work suggest there are functionally distinct classes of
ASD-associated genes (3, 8, 73). While phenotypic profiles were
continuously distributed, certain genes were closer to each other
than others in a manner that reflected underlying molecular in-
teractions. The observation that ASDs are a group of etiologically
distinct and variably phenotypically similar disorders provides
further motivation for tailored treatments designed on the bases of
shared molecular pathway disruptions (3, 73).
For the majority of genes studied in this work, there is a clear
C. elegans ortholog with a loss-of-function mutation available
from stock centers, oftentimes in an outcrossed strain to mini-
mize the effects of background mutations. For some genes,
orthology relationships are less clear, and there was a paucity of
outcrossed deletion alleles, making the functional annotations
added onto these genes provisional at this point. This limitation
becomes less important when the same phenotypes were observed
in 2 strains carrying independently generated alleles of the same
gene, when the phenotypes were rescued by expression of the wild-
type allele, or when the phenotypes were observed in a strain
generated with CRISPR-Cas9 genome editing. As such, the reader
should gauge the confidence of the genotype-to-phenotype rela-
tionships reported for individual strains accordingly when de-
signing follow-up studies, an approach that has proven to be
straightforward and extremely valuable when applied to previous
large-scale phenotyping of baseline locomotion in similarly gen-
erated C. elegans knockout libraries (46, 47, 68, 74).
It is also important to consider whether the functions of ASD-
associated genes discovered here will be conserved to their human
orthologs, and, if they are conserved, whether they display speci-
ficity to ASD. Regardless of the qualitative diagnostic label ap-
plied, understanding the functions of these poorly characterized
neurodevelopmental disorder-associated genes will be valuable for
understanding pathology and designing treatments. Further, un-
derstanding gene functions that may not be specific to ASD pa-
thology (e.g., seizures) can still be useful in diagnosis or treating
comorbidities. Even in cases where a given gene may be implicated
in multiple disorders, or where a deletion allele may not be the
best model of genetic etiology, understanding the consequences of
loss of function in that gene can offer valuable insights that aid in
the interpretation of the functional impact of particular risk vari-
ants that may be specific to a given disease pathology. Regarding
conservation of function, several of the shared functions for ASD-
associated gene orthologs identified here, such as promoting
normal development or habituation of response probability, have
concurrently been discovered in higher model organisms and hu-
man iPSCs, suggesting many of the other functions reported here
will also be conserved. Indeed, our analysis and previous work in
other model systems suggest that ASD-associated genes are highly
conserved throughout evolution (75). It is also worth reiterating
that many human genes have been shown to functionally replace
their C. elegans orthologs. For example, human NLGN1 and
NLGN4 have both been shown to rescue multiple sensory ab-
normalities caused by loss of C. elegans nlg-1 (33, 76). We have also
recently shown that directly replacing daf-18 with only a single
copy of its human ASD-associated ortholog PTEN at the endog-
enous locus using CRISPR-Cas9 is able to rescue multiple sensory
abnormalities caused by complete deletion of daf-18 (31). Indeed,
it would not be surprising if a highly conserved human gene could
replace its C. elegans ortholog. All model systems have their rel-
ative strengths and weaknesses, and the fastest and most gener-
alizable insights in ASD research will undoubtedly come from
synthesis of large amounts of information derived from diverse
model systems and studies of individuals with ASD.
Phenomic Profiles Can Be Leveraged for In Vivo Assays of Missense
Variant Effect.We used neuroligin as a proof of principle to show
how our phenomic profiles can be leveraged to establish in vivo
variant functional assays. We found that all neuroligin variants
tested displayed partial loss of function despite effective expression
and proper subcellular localization. Further, we observed that
variant functional results were consistent across multiple behav-
ioral functional assays involving distinct neural circuits. While the
neurobiological mechanisms underlying the behavioral effects of
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ASD-associated neuroligin variants currently remain controversial
(different studies have implicated altered receptor trafficking,
circuit-specific electrophysiological imbalances, etc.) (77–82), our
results suggest that a treatment should be designed to increase
neuroligin function while taking into account the presence of an
existing dysfunctional protein. We also assessed several missense
variants in chd-7 and observed habituation impairments in a sub-
set, further prioritizing these candidates for future study (61).
Importantly, all strains were significantly different from wild-type
on at least one metric, allowing for many diverse in vivo variant
functional assessments moving forward. Many genes were signifi-
cantly different on multiple metrics, giving researchers with in-
terests in particular biological processes the ability to choose a
phenotypic functional assay most suited to their needs. A strength
of C. elegans will continue to be the ability to rapidly assess mul-
tiple variants in complex sensory and learning behaviors in vivo.
Harnessing Phenotypic Profiles for Tests of Adult Reversibility. We
found that adult expression of neuroligin could partially reverse
the impaired habituation phenotypes of animals that developed
without neuroligin. Interestingly, we also found that adult-specific
inactivation did not produce phenotypic disruptions. These results
are surprising, as inactivation of NLGN1, NLGN2, and NLGN3 in
mature vertebrates produces abnormalities in several complex
behaviors (63, 64, 83). However, a plausible explanation could be
that neuroligin is only necessary in adulthood for forms of learning
and memory that require structural plasticity. Indeed, all studies
reporting an adult requirement for neuroligin examined different
forms of long-term memory, which, in contrast to the short-term
memories studied here, require de novo activity-dependent syn-
apse growth and maturation. Further, the phenotypes observed
often did not manifest until weeks after neuroligins were inacti-
vated in adult animals (64). These results led to a model in which
neuroligin is sufficient to build a circuit capable of normal sensi-
tivity and short-term habituation at any point throughout the
lifespan, but, once that circuit has been built, its function is no
longer required for short-term learning. Continued function of
neuroligin would then remain necessary only for more complex
forms of long-term learning and memory that require de novo
activity-dependent growth and maturation of synaptic connections.
The C. elegans nervous system is thought to have largely invariant
connections across individuals, and there is no clear evidence
yet of new synapse formation underlying long-term learning in
C. elegans, making this model currently difficult to test. How-
ever, an adult form of experience/activity-dependent neural
circuit remodeling where neural activity driving male mating
behavior rewires synaptic connections has recently been discovered
in C. elegans, and neuroligin was identified as a critical component
in this process (84). These results suggest that some phenotypic
alterations due to developmental loss of neuroligin may be re-
versible in adulthood. More broadly, they provide a rapid and
inexpensive strategy where AID can be used to test reversibility of
phenotypic disruptions caused by diverse ASD-associated genes
and thereby prioritize candidates for further study in less evolu-
tionarily distant model systems with greater translational potential.
Conclusions
We have completed a systematic phenomics analysis of ASD-
associated genes and identified shared delays in development,
hyperactivity, and impairments in habituation learning. Our data
add to the rapidly expanding use of model organism phenomics
to discover the functions of poorly characterized genes identified
through genomic sequencing (9, 31, 85–87). We have shown how
such data can be used to identify genetic interactions, establish
variant functional assays, and develop tests of phenotypic re-
versibility. This work sets the stage for numerous future experi-
ments using cell-specific and inducible genetic manipulations to
delineate each of the specific mechanisms through which muta-
tions in these genes produce their emergent phenotypic profiles.
There is substantial evidence that an insufficient understanding
of the biology of many disease-associated genes has prevented
the successful development of therapies and that preclinical re-
search is biased toward experimentally well-accessible genes
(88). It is ideal to be systematic and unbiased whenever possible,
an opportunity high-throughput model organisms such as C.
elegans afford and thus one we should continue to exploit. As we
continue to chart the phenotypic landscape of ASD-associated
genes, the complicated paths to understanding mechanisms and
developing personalized treatments become simpler to navigate.
Materials and Methods
Ortholog identification, machine vision phenotypic analyses, behavioral
assays, statistical analyses, cloning, genome editing, auxin administration,
and confocal imaging are described in SI Appendix, SI Materials and
Methods. Briefly, Bristol N2 animals were used as the wild-type C. elegans
strain. Strains were maintained on NGM (nematode growth medium) plates
seeded with Escherichia coli strain OP50 according to standard experi-
mental procedures. At 96 h posthatch, hermaphrodite animals grown and
tested at 20 °C were used for all experiments in the large-scale character-
ization. All C. elegans strains used in this study are listed in the SI Appendix.
Transgenic strains were generated by microinjection of transgene DNA or
by genetic crosses.
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